Translating the effects of mTOR on secretory senescence

Kosuke Tomimatsu1, Masashi Narita1

  • 1University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.

Nature Cell Biology
|October 1, 2015
PubMed

Insights

Cellular senescence triggers a secretory phenotype impacting tissues. The mammalian target of rapamycin (mTOR) pathway controls this by regulating gene expression and mRNA stability.

Area of Science:

  • Cellular and Molecular Biology
  • Aging Research
  • Biochemistry

Background:

  • Cellular senescence is a state of irreversible growth arrest.
  • Senescence-associated secretory phenotype (SASP) involves secreted factors influencing the microenvironment.
  • The role of mTOR in regulating senescence was previously unclear.

Discussion:

  • The mammalian target of rapamycin (mTOR) pathway is a key regulator of protein synthesis.
  • mTOR influences cellular senescence by controlling gene transcription.
  • mTOR also modulates mRNA translation and stabilization, impacting SASP.

Key Insights:

  • mTOR is a central regulator of the senescence-associated secretory phenotype (SASP).
  • The pathway affects SASP through transcriptional, translational, and post-transcriptional mechanisms.
  • This finding links a major metabolic regulator to a fundamental aging process.

Outlook:

  • Further investigation into mTOR's role in aging and age-related diseases.
  • Therapeutic targeting of mTOR to modulate SASP and its consequences.
  • Exploring downstream targets of mTOR in senescence for novel interventions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K